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ABSTRACT 
 
Sulphation is a crucial modification which is required for normal growth and development. 
Sulphation reactions are mediated through the universal sulphate donor 3’-phosphoadenosinse 
5-phosphosulfate (PAPS). PAPS is synthesised in a two step process by the bi-functional 
enzyme 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPSS), which contains both APS 
kinase and ATP sulphurylase. There are two forms of PAPSS, PAPSS1 and PAPSS2. 
PAPSS2 is important for normal skeletal development and has two different isoforms, 
PAPSS2a and PAPSS2b. It was hypothesised that knock-downs of the PAPSS2a and 
PAPSS2b genes would lead to alterations in the phenotype of developing zebrafish embryos. 
 
In Situ hybridisations were undertaken on zebrafish embryos at days 1, 2 and 3 using anti-
sense probes for PAPSS2b. This allowed for confirmation of the expression of PAPSS2b 
within the zebrafish and also to locate the areas where it is expressed. Once expression of 
PAPSS2b had been confirmed within the zebrafish morpholino knock-downs were also 
undertaken for both the PAPSS2a and PAPSS2b genes. Four separate concentrations were 
used for the morpholino knock-downs (10μM, 30μM, 100μM, and 300μM). Splice site and 
translational blocking morpholinos were used to induce the gene knock-down and a scramble 
morpholino control was used. Successful knock-down of PAPSS2b was recorded using PCR 
when 100μM and 300μM concentrations of the morphlolino were used, the development of 
the embryo were monitored for the first four days of development and those which had the 
morpholino knock-down of PAPSS2b had a different phenotype to the controls by which their 
head was slightly smaller. For PAPSS2a the knock-down of the gene was unable to be 
confirmed due to the PCR not detecting any gene product in any of the injected zebrafish. 
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ABBREVIATIONS 
 
PAPS = 3’-phosphoadenosine 5-phosphosulfate  
PAPSS = 3’phosphoadenosine 5-phosphosulfate synthase 
SULT = sulphotransferases 
DNA = deoxyribonucleic acid 
cDNA = complementary deoxyribonucleic acid 
APS kinase = Adenylyl-sulfate kinase 
ATP sulphurylase = Adenosine triphosphate sulphurylase 
ADP = Adenosine diphosphate 
SEMD = spondyloepimetaphyseal dysplasia 
LB = Lysogeny Broth 
dNTP = Deoxyribonucleotide 
PCR = polymerase chain reaction 
PBST = phosphate buffered saline with tween 20 
bm = brachymorphism 
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1 INTRODUCTION 
1.1 The role of sulphation in metabolism 
Sulphation is a crucial modification of many proteins, carbohydrates, and lipids which is 
required for normal growth and development[7]. Sulphation reactions are mediated through 
the universal sulphate donor 3’-phosphoadenosinse 5-phosphosulfate (PAPS)[9]. A sulphation 
reaction consists of the transfer of a sulphate group from PAPS to a wide variety of substrates, 
and is catalysed by sulphotransferase enzymes[13]. Sulphation is a high-affinity enzymatic 
process. Notably the entire liver content of PAPS can be used up within 2 minutes[2]. 
 
Sulphation has an impact on many physiological processes, including; deactivation and 
bioactivation of xenobiotics, inactivation of hormones and catecholamines, alteration of 
structure and function of macromolecules, and elimination of end products of catabolism[13]. 
Under normal physiological conditions, sulphation is partially regulated by the quantity of 
PAPS available and the transport mechanisms by which sulphated conjugates enter and 
leave[2]. 
1.2 3’-phosphoadenosinse 5-phosphosulfate 
 
PAPS is critical to sulphotransferase reactions, where it acts as a sulphate donor. The 
synthesis of PAPS in higher animals, including mammals is mediated by the bi-functional 
enzyme 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPSS)[2], in a two step process. 
Firstly ATP sulphurylase, catalyses the formation of adenosine 5’-phosphosulfate (APS) from 
ATP and free sulfate, and secondly APS kinase phosphorylates the previously produced APS 
to form PAPS[4]. Following this, sulphotransferases (SULT) transfer sulphate, donated by 
PAPS, to an acceptor substrate. In mammalian cells, PAPS is needed for the sulphonation of 
proteins, hormones, neurotransmitters, carbohydrates, lipids, drugs and xenobiotics[16]. 
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Figure 1 The synthesis of PAPS.  
In step A PAPS is produced from ATP and SO42- using both the ATP sulphurylase and the 
APS kinase activities of PAPSS. In step B SULT transfers a sulphate from PAPS (leaving 
PAP) to an acceptor substrate[5]. 
 
1.3 3'-phosphoadenosine 5'-phosphosulfate synthase 
 
As described in 2.2 the PAPSS enzyme produces PAPS by a two stage reaction using both its 
APS kinase and ATP sulphurylase activities. PAPSS enzymes are crucial for all sulphation 
reactions. Within bacteria, fungi and yeast the two functionally distinct enzymes (APS kinase 
and ATP sulphurylase) are located on separate polypeptide chains. Within the marine worm 
U.caupo the mouse and human, APS kinase and ATP sulphurylase consist of a single bi-
functional enzyme, PAPSS[4]. The cDNA which encodes the PAPSS gene has also been 
identified in the nematode C-elegans, thus providing further evidence that the fusion of APS 
kinase and ATP sulphurylase activity onto a single enzyme is conserved within animals[4].  
Sequence comparisons have been carried out between sequences with APS kinase and ATP 
sulphurylase located on a single cDNA and also separate APS kinase and ATP sulphurylase 
sequences. These comparisons have shown that the bi-functional enzymes have a conserved 
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organisation, where the APS kinase activity is located to the N-terminus, and the ATP kinase 
activity is located to the C-terminus of the bi-functional enzymes[4]. The amino acid 
sequences of APS kinase, and ATP sulphurylase are highly conserved throughout evolution, 
regardless of whether they have fused to form a single protein, or are encoded by separate 
genes[4]. These observatiions suggest that vetibrate animal models have a human-like enzyme 
function and structural relationship. This enables the zebrafish to be a potential model for 
study of the PAPSS enzyme. 
 
Within human tissue two separate PAPSS cDNAs have been identified[1], termed PAPSS1 
and PAPSS2. These two isoforms of the PAPSS gene are similar, both consisting of 12 exons, 
and having virtually identical exon-intron splice junction locations[1]. The lengths of the 
genes do differ, with PAPSS1 being 108kb, and PAPSS2 145kb[1]. This size difference is 
also reflected in the size of the transcript, with PAPSS1 having a transcript of 2.7kb and 
PAPSS2 having a transcript of 4.2kb[1]. The two isoforms also map to chromosomes. 
PAPPS1 maps to the human chromosome band 4q24, and PAPSS2 maps to 10q22-23[1]. 
Despite these variations both PAPPS1 and PAPSS2 contain the ATP-sulphurylase domain 
and an APS-kinase domain critical to its function. Sequence similarity for PAPSS1 and 
PAPSS2 carried out on the coding regions of the APS kinase and ATP synthase domains have 
revealed 73% homology within the cDNA, and 76% similarity within the protein sequence[2].  
 
The expression patterns between PAPSS1 and PAPSS2 varies substantially[2]. PAPSS1 is 
expressed within the testis, pancreas, kidney, thymus, prostate, ovary, small intestine, colon, 
leukocytes, cartilage and liver[2]. PAPSS2 is predominantly located within in the liver 
cartilage and adrenal glands[8]. Animal studies have indicated that PAPSS2 is the more 
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abundant isoenzyme in developing tissues that have a high sulphonation requirement, such as 
cartilage. PAPSS2 also has two alternatively spliced transcript variants encoding two different 
isoforms, these are PAPSS2a, and PAPSS2b. 
 
Several studies have indicated that PAPSS2 activity is important for normal skeletal 
development. It has been found that mutations within PAPSS2 are responsible for abnormal 
skeletal development in human spondyloepimetaphyseal dysplasia and murine 
brachymorpism[15]. Pakistani type spondyloepimetaphyseal dysplasia is characterised by 
short stature, short and bowed lower limbs, mild brachydactyly, kyphoscoliosis, abnormal 
gait, enlarged knee joints, and precocious osteoarthropathy[2]. Also defects within PAPSS2 
have been linked to perturbed foetal bone development[9]. 
1.4 The zebrafish as a model organism 
 
Over recent years the zebrafish has emerged as a key model organism for the study of 
developmental processes[17]. Within this project the zebrafish will be used as the model 
organism to study the localisation of the PAPSS2b gene and also the developmental effects of 
a PAPSS2b gene knock-down.  Research undertaken on zebrafish has led to advances in the 
fields of developmental biology, oncology, toxicology, reproduction, stem cell and many 
more. 
There are many reasons why zebrafish have been successful as a model organism. Firstly they 
have a fully sequenced genome, which has been shown to be highly similar to the human 
genome[7]. This has led to the generation of a dense genetic map allowing for comparative 
mapping of human genes[11]. Zebrafish and humans also share high similarity in 
developmental processes, physiology and behaviour[10]. 
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Zebrafish also have rapid embryonic development[10], and transparent embryos which 
develop outside the mother so they are ideally suited for studying developmental processors 
as they occur[10]. Due to the permeability and transparency of the zebrafish embryo[18], 
developing organ primordia in the whole mount specimen can be readily detected in situ 
hybridizations[19]. 
 
Zebrafish also produce many offspring in a short period of time allowing for ease of repetition 
of experiments, and gene knock-down using morpholino constructs which has made genetic 
manipulations possible[17]. 
 
Zebrafish also contain both PAPSS2a and PAPSS2b isoforms, as seen within humans. Within 
zebrafish the PAPSS2a and PAPSS2b isoforms originate from a gene duplication event, 
whereas in humans the two isoforms are formed via alternative splicing. 
1.5 Adrenal gland development in humans and zebrafish 
 
The adrenal gland is an area where PAPSS2b has been shown to localise to[21]. For this 
reason it is hypothesised that this is an area where an effect will be seen with a PAPSS2b gene 
knock-down in the developing zebrafish.  
 
In humans the adrenal gland formation occurs within the first two months of development, the 
development within zebrafish is however far quicker. Various groups have shown that 
interrenal development in the zebrafish shares many conserved molecular and developmental 
mechanisms with higher vertibrates[19]. 
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Zebrafish belong to the teleost group and therefore do not possess a distinct adrenal gland[11]. 
They do however contain an intermingled group of cells located in the anterior kidney which 
produces either catecholamines or steroid hormones[11]. The catecholamine-producing cells 
are derived from embryonic neural crest cells, while the interenal cells are derived from 
mesoderm[11] both glucocorticoid and mineralocorticoid are secreted. 
 
In zebrafish there is parallel development of interrenal steroidogenic and catecholamine 
producing-chromaffin cells which resembles the formation of the adrenal gland in 
mammals[12]. Also, similar to the mammalian adrenal medulla, the chromaffin component of 
the interrenal organ is originated from the neural crest through sequential steps of 
differentiation[12]. 
1.6 The interaction between endocrine hormones and bone 
 
Bone and cartilage are both areas where PAPSS2b has been shown to localise to during 
development[21]. For this reason it is hypothesised that the cartilage formation within the 
zebrafish will be affected by a PAPSS2b gene knock-down.  
 
Bone together with cartilage, makes up the skeletal system which allows for multiple 
mechanical and metabolic functions, for example providing support for muscle attachment, 
protecting vital organs, and serving as a reserve of ions[6]. 
 
Several studies have indicated that PAPSS2 activity is important for normal skeletal 
development. A mutation within the PAPSS2 gene causes a skeletal disorder in humans, 
spondyloepimetaphyseal dysplasia (SEMD), Pakistani type. The clinical signs include short 
stature which is evident at birth[2]. 
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Other studies have shown that a mis-sense mutation within the PAPSS2 gene leads to 
brachymorphism (bm) in mice[2]. bm leads to abnormal hepatic detoxification, bleeding 
times, and postnatal growth. The skeletal phenotype of the bm mice has been linked to 
reduced sulphation of the proteoglycans of the cartilage extracellular matrix[2]. 
 
Deficiency of PAPSS2 results in osteochondrodysplasias. Osteochondrodysplasias are a 
genetically heterogeneous group of disorders that affect skeletal development, linear growth, 
and the maintenance of cartilage and bone[8]. 
1.7 Hypothesis and aims 
 
The project will aim to look into how these clinically important enzymes behave within a 
zebrafish model, and hence find if the zebrafish is a suitable model organism in which to test 
the impact of sulphation reactions on bone metabolism. This will include in situ hybridisation 
of day 1, 2 and 3 embryos using PAPSS2b probes to test the localisation of the gene within 
the zebrafish. Morpholino knock-downs of both the PAPSS2a and PAPSS2b genes will be 
used to observe any change in phenotype through the first four days of development. 
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2 METHODS 
2.1 Making Agar plates 
 
10g of LB, 10g of agar and 400ml of water were added to a 500ml bottle. The solution was 
then autoclaved. The media was left to cool until hand hot, following this ampicillin was 
added. If the agar had already solidified in the bottle then it was heated up in the microwave 
until melted. The liquid media was then poured into Petri dishes and left to set at room 
temperature. 
2.2 Transformation 
 
Competent cells (Alpha select, bronze efficiency) were placed on ice to thaw. Once thawed 
10ng of plasmid DNA was added to the cells, keeping everything on ice. The cells were then 
incubated on ice for 30 minutes. Following this the cells underwent heat shock at 37˚C for 30 
seconds, using a heat block. They were then placed back on ice for 2 minutes, then 200μl of 
LB was added to the cells, and then they were incubated  at 37˚C  using the heat block for 30 
minutes and spread on a pre-warmed LB plate with ampicillin. The plate was allowed to dry 
at room temperature and then incubated at 37˚C overnight. 
2.3 Mini preps 
 
The tubes containing the overnight cultures (3.3) were spun down for 5 minutes at maximum 
speed in the centrifuge at room temperature. The supernant was removed from the tubes 
leaving the pellet. The pellet was then re-suspended with 250μl of P1 (6.1 g Tris, 3.7 g 
EDTA-2H2O pH 8.0 w/ HCl/1 liter, 100 μg/ml RNAse A, 10 mg RNase in 100 ml batches, 
store 4 degrees). Once the pellet had been re-suspended the solution was transferred into an 
eppendorf. 250μl of P2 (8.0 g NaOH in 900 ml H2O, 100 ml of 10 % SDS/1 liter, store room 
temperature) was added to the re-suspension and the eppendorf invert 5/6 times until a blue 
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colour is consistent. 350μl of N1 was then added and the eppendorf was inverted 5/6 times 
until the blue colour disappeared. The sample was then spun down for 10 minutes on 
maximum speed using the micro centrifuge at room temperature. The supernant was added to 
a spin column and centrifuged for 45 seconds at maximum speed using the micro centrifuge at 
room temperature and the flow through was discarded. 750μl of buffer PE was then added to 
the spin column, and centrifuged for 1 minute on maximum speed using the micro centrifuge 
at room temperature, the flow through was discarded. The sample was centrifuged again for 1 
minute at full speed using a micro centrifuge at room temperature and the flow through was 
discarded. The spin column was placed into a fresh eppendorf, and 50μl of buffer EB (10 mM 
Tris, pH 8.5) was added. This was then centrifuged for 1 minute at maximum speed using a 
micro centrifuge at room temperature and then spin column was discarded. 
2.4 Making an 0.8% Agarose gel 
 
0.8g of agarose was weighed out using weighing scales, per 100ml of TBE measured using a 
measuring cylinder. Both of these were added to a conical flask. The mixture was heated in 
the microwave until the agarose dissolved into the solution, making sure that the solution is 
checked every 20 seconds and mixed. The solution was left to cool for 10 minutes until hand 
hot and 5μl of Cybersafe (Invitrogen) per 100ml of the solution was added and mixed. The 
solution was then poured into the gel mould and left to set for around 30 minutes. The rubber 
seals and the combs were then removed from the gel mould, and it was placed into the 
electrophoresis apparatus making sure that it was covered with TBE, adding some if 
necessary. 
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5μl of hyperladder 1 was added to the first well using a pipette, and 5μl of the sample/s was 
added to the following well/s, using a pipette. The gel was electrophoreted at 90V for around 
30 minutes. 
2.5 Digestion 
 
A typical linearisation digest consisted of 1μl of EcoR1, 6μl of the DNA to be digested, 4μl of 
buffer 4, and 11μl of water in an eppendorf. This was left at 37˚C using the heat block for 2 
hours. 
2.6 PCR 
 
10μl of buffer, 5μl of primer 1, 5μl of primer 2, 1μl of dNTP, 2μl of MgCl2, 0.5μl of fusion, 
25.5μl of dH2O, and 1μl of DNA, or 39μl of blue, 1μl of DNA, 5μl of primer 1, 5μl of primer 
2 was added to an eppendorf. The primers used were: 
Primer Primer sequence 
PAPSS2a mRNA gcagaattcaaactaccttccaactcacctg 
PAPSS2a mRNA gcagaattccgaataagatatacagaaatctcagagac 
PAPSS2a cDNA gcagaattcatgcctggaaacaaaacactg 
PAPSS2a cDNA gcagaattctcactggactttctgtagggaag 
PAPSS2a splice (1777) gcagaattcctccgggactaagatgcgcaag 
PAPSS2b mRNA gcagaattcattaactgtgtcttggtcccttag 
PAPSS2b mRNA gcagaattcgtttattggaatggctgcccgatg 
PAPSS2b cDNA gcagaattcatgtctgggatgaagaagcagag 
PAPSS2b cDNA gcagaattctcactggtctttcttcagagaac 
PAPSS2b splice (1685) gcagaattcaccaggcctcacctctctcg 
 
This was then processed through a PCR cycle according to the following programme: 
 
 
Stage Temperature/C Time/ minutes 
Hold 94 5 
Elongation  
(x35) 
94 0.5 
60 0.5 
72 1 
Hold (x2) 72 5 
End 4  
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2.7 Sequencing 
 
Sequencing was carried out by biosciences. The following sequencing primers were used: 
 
Primer Start (bp) Primer sequence 
PAPSS2a fwd 421 tttgaggtgtttgtgaac 
PAPSS2a fwd 841 gacacccttctggaag 
PAPSS2a fwd 1260 ggacacacgtcgaag 
PAPSS2a fwd 1681 ttttatgacaaagacagac 
PAPSS2a rev 280 cgatcctctgaggtg 
PAPSS2a rev 770 aacacctgcacccac 
PAPSS2a rev 1120 ttctctccaaaacctc 
PAPSS2a rev 1540 tcccagcaggatcac 
PAPSS2b fwd 431 aagtgtttgtaaatgctc 
PAPSS2b fwd 882 tgttccaattgtgcttc 
PAPSS2b fwd 1425 catcgtggccattttc 
PAPSS2b fwd 1692 cgacaaggaaagacatg 
PAPSS2b rev 198 gactagatattcttccag 
PAPSS2b rev 647 ggtacaatatcctgttc 
PAPSS2b rev 1095 cagccaatccccac 
PAPSS2b rev 1490 cgacaatgccattgtac 
 
2.8 Ligation 
 
A typical ligation reaction was carried out by adding 1μl T4 DNA liagase, 1.5μl T4 DNA 
ligation buffer, 2μl PCS2+ (vector), and 10μl DNA insert to an insert followed by incubation 
overnight at room temperature. 
2.9 Purifying PCR products from gels 
 
The Cybersafe stained gel was observed under UV light in the dark room and the desired band 
identified by size and migration was excised using a scalpel removing as little excess gel as 
possible. The DNA fragment was placed into an eppendorf. The gel was then weighed and 3 
volumes of buffer QG to one volume of gel (100mg = 100μl) was added, and incubated at 
50˚C for 10 minutes (or until the gel slice has completely dissolved). After the gel slice had 
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dissolved completely 1 gel volume of isopropanol was added to the sample and mixed. The 
sample was placed into to the QIAquick column, and centrifuged for 1 minute at full speed at 
room temperature using a table top centrifuge. The flow through was discarded and 0.75ml of 
buffer PE was added to the QIAquick column and centrifuged for 1 minute at 13,000rpm at 
room temperature using a table top centrifuge. The flow through was discarded and the 
QIAquick column was centrifuged for an additional 1 minute at maximum speed at room 
temperature using a micro centrifuge. The QIAquick column was then placed into a clean 
1.5ml micro centrifuge tube. And 50μl of buffer EB was added to the centre of the QIAquick 
membrane and then centrifuged for 1 minute at maximum speed at room temperature using a 
micro centrifuge. 
2.10 Purifying from PCR products from PCR reactions 
 
5 volumes of buffer PBI was added to 1 volume of the PCR sample. The QIAquick spin 
column was placed into a 2ml collection tube. The sample was then placed into the QIAquick 
column and centrifuged for 1 minute at maximum speed at room temperature in a table top 
centrifuge. The flow through was discarded and the column was centrifuged for an additional 
minute at maximum speed, at room temperature using a micro centrifuge. The QIA quick 
column was then placed into an eppendof and 50μl of buffer EB was added to the centre of 
the QIAquick membrane and centrifuge the column for 1 minute at 13,000rpm at room 
temperature using a micro centrifuge. 
2.11 Obtaining zebrafish embryos 
 
The day before the egg harvesting the zebrafish were placed into fresh tanks with the males 
and females separated by dividers with one male and one female per tank. The zebrafish were 
then left overnight. The following day the dividers were removed from between the zebrafish 
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and they were left for 15 minutes to lay. Once the eggs had been laid they were transferred 
into a Petri dish containing fresh water. The eggs were removed from the Petri dish using a 
pipette and placed in a clean dry Petri dish lid. The excess water was removed from the eggs 
using a pipette. Using another pipette with a fine tip the eggs were arranged so that none were 
overlapping. 
2.12 Micro-injection of morpholino solutions into embryos 
 
Morpholino solutions were made by adding 2μl of phenol red, 0.5μl of CFP RNA, 1μl of the 
morpholino of the given concentration (10µM, 30µM, 100uµM, or 300¥M), and 6.5μl of 
water to an eppendorf and this was kept on ice. Morpholino solution was pippeted into the tip 
of the needle. The needle was inserted into the embryo and the morpholino solution was then 
injected into the embryo. 
 
The morpholino sequences used were: 
 
 
2.13 Preparation of in-situ probes for PAPS localissation 
 
10μg of PSC2+ plasmid DNA, 5μl of restriction enzyme (Not1 was used to produce the sense 
probe and BamH1 was used to produce the anti-sense probe), 5μl of 10x buffer and sufficient 
dH2O to give a final volume of 50μl was added to an eppendorf. This was incubated for 1.5 
hours at 37˚C and then left overnight at 4°C. 2.5μl of 10% SDS and 1ul of Proteinase K 
Gene Target Morpholino sequence 
PAPS2a Translational blocking tatccagtgttttgtttccaggcat 
PAPS2a Splice junction agacctgcagaaacaaacacaaagt 
PAPS2b Translational blocking ttctctgcttcttcatcccagacat 
PAPS2b Splice junction cgatcctatcgtcaggacattaaaa 
Control Scramble ttctatctacgtgtagctgtacttg 
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(10ng/μl) was added and incubated for 15 minutes at 55˚C using the heat block. 100μl of 
1xTE and 100μl of Phenol/Chloroform was then added and the mixture was mixed by 
vigorous shaking. This was then centrifuged for 10 minutes at 7000 rpm in a table top 
centrifuge at 4˚C. The upper phase was placed into a new eppendorf, and 100μl of chloroform 
was added and the solution was mixed by vigorous shaking. The solution was then 
centrifuged for 10 minutes in a table top centrifuge at 7000 rpm at 4˚C. The upper phase was 
transferred into a new eppendorf, and 10μl of Sodium Acetate (pH 5.2) and 250μl of 100% 
ethanol was added and this was keep for 30 minutes at -80˚C. The solution was then thawed 
on ice for 15 minutes, and then centrifuged for 10 minutes in a table top centrifuge at 12000 
rpm at 4˚C. The supernant was discarded and the pellet was washed with 80% ethanol. This 
was then centrifuged for 5 minutes in a table top centrifuge with 12000 rpm at 4˚C and the 
pellet was left to air-dry. The pellet was then re-suspended in 20μl of nuclease free water. 2μl 
of 10xtranscription buffer, 2μl of 10xDIG RNA labelling mix, 1μl of RNase inhibitor, 1ug of 
the cut vector template, 2μl of T7 polymerase, and enough nuclease free water to give a final 
volume of 20μl was added to an eppendorf, and incubated for 2 hours at 37˚C using the heat 
block. 2μl of RNase free DNase was added and left for 15 minutes at 37˚C using the heat 
block. 10μl of 7.5M NH4Ac and 75μl of 100% ethanol was added and this was left at -80˚C 
for 20 minutes. Following this it was centrifuged for 15 minutes in a table top centrifuge at 
12000 rpm at 4˚C. The pellet was washed with 80% ethanol and the pellet was left to air dry. 
The pellet was then re-suspend in 20μl of hybridisation buffer and stored at -20˚C. 
2.14 In situ hybridisation 
 
Dilutions of methanol of 75%, 50%, and 25% using phosphate buffered saline with tween 20 
(PBST) were made up. The embryos were washed in 1ml 75% methanol, 50% methanol, and 
25% methanol, leaving each for 5 minutes at room temperature. The embryos were then 
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washed four times in PBST leaving each for 5 minutes at room temperature. 4μl of proteinase 
K (10μg ml-1) was added and left at room temperature for 10 minutes on the shaker. The 
embryos were then washed in 1ml of PBST for 5 minutes. 2mls of 4% PFA was added and 
left for 20 minutes at room temperature. The embryos were then washed four times in PBST, 
5 minutes per wash at room temperature. 500μl of hybridisation buffer was added and left for 
3 hours in a 70˚C water bath. Then the hybridisation buffer was replaced with fresh 
hybridisation buffer and 1μl of either the sense or antisense probe. This was then placed in the 
70˚C water bath overnight. The embryos were then washed twice for 30 minutes each with 
1ml of 50:50 at 70°C in the water bath. The embryos were then washed for 15 minutes each 
with 1ml of 2xSCC at 70°C in the water bath. The embryos were then washed twice for 30 
minutes each with 1ml of 0.2xSCC at 70°C in the water bath. 1ml of blocking buffer was then 
added and left for 3 hours at room temperature. The blocking buffer was then replaced with 
1ml of anti-DIG antibody solution diluted to 1/4000 and left overnight at 4˚C. The embryos 
were then washed in 1ml of PBST six times for 20 minutes each at room temperature. The 
embryos were then washed in 1ml of staining buffer twice for 5 minutes each at room 
temperature, and then transferred to 12 well plates. 1ml of staining solution was then added at 
room temperature and then placed in the dark. Once the desired amount of staining was been 
achieved the embryos were washed in 1ml of PBST and then 2mls of 4% PFA was added. 
2.15 Imaging in situ hybridisation staining 
 
The PFA was removed and 25% glycerol in PBST was added and left for 1 hour at 4°C. Then 
the 25% glycerol was removed and 50% glycerol in PBST was added and left for 1 hour at 
4°C. Then the 50% glycerol was removed and 75% glycerol in PBST was added and left for 1 
hour at 4°C. Then the 75% glycerol was removed and 100% glycerol was added and left 
overnight at 4C. Slides were set up with 5 pieces of tape layered either side of the slide. A 
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drop of 100% glycerol was placed in the centre of the slide and on one embryo was placed on 
to image. The cover slip was placed over the embryo and moved in order to orientate the 
embryo for a top view and a side view. 
2.16 Removing chorions and fixing embryos 
 
1ml of pronase was added to the petri dish containing the embryos in about 1ml of water and 
left for 10 minutes. The petri dish was shaken to try to remove the embryos from their 
chorions. This was repeated every 3 minutes until two thirds of the embryos had been 
removed from their chorions. The petri dish was then placed into a beaker water containing, 
1/3 cold water, 1/3 warm water, and 1/3 distilled water. The water was then poured off the 
embryos leaving them at the bottom of the beaker. The beaker was then tilted to a 45 degree 
angle and a beakers worth of water was poured down the side. This was repeated until all of 
the embryos were removed from their chorions. Once all of the embryos were free from their 
chorions the excess water was removed and the embryos were placed into an eppendorf tube. 
1.5ml of 4% PFA was added to the embryos and they were left at 4C overnight. The 
following day the PFA was removed and 1ml of 25% methanol in PBST was added and left 
for 5 minutes at room temperature. This was then replaced with 1ml of 50% methanol in 
PBST and left for 5 minutes at room temperature. This was then replaced with 1ml of 75% 
methanol in PBST and left for 5 minutes at room temperature. This was then replaced with 
1ml of 100% methanol and stored at -20˚C. 
2.17 RNA extraction and DNase treatment 
 
15 embryos were added to an eppendorf tube and 100μl TRIZOL was added. The embryos 
were then homogenised with a pestle. 90μl TRIZOL was then added to each sample and 
pipetted up and down several times. The sample was then left at room temperature for 5 
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minutes. 200μl of chloroform was then add and the sample shaken vigorously. It was then left 
at room temperature for 3 minutes. The sample was then centrifuged at 6000rpm for 10 
minutes at room temperature. 400μl of the top phase was then transferred into a fresh 
eppendorf and 400μl of isopropanol was added. This was then centrifuged at top speed in a 
microcentrifuge for 30 minutes. The pellet was then washed with 1ml of 75% ethanol and 1ml 
of ethanol was added. The sample was then centrifuged for 20 minutes. The supernant was 
removed and the pellet was left to air-dry for 10 minutes. The pellet was then re-suspended in 
17μl of nuclease-free water. 2μl of DNase buffer and 1μl DNase was added to the sample, and 
then incubated at 37˚C for 30 minutes. 2μl of inactivation buffer was then added and the 
sample was kept at room temperature for 5 minutes. The sample was then centrifuged at 
10000rpm for 90 seconds at room temperature in a table top centrifuge, and the supernant was 
placed into a fresh tube. 
2.18 cDNA synthesis 
 
Once the RNA had been extracted it was reverse transcribed so that cDNA for use in the real-
time PCR. The reverse transcription generated 50ng of cDNA/μl from 20μl of the initial 
reaction volume. (2.0μl of 10xRT Buffer, 4.4μl 25mM MgCl2, 4.0µl dNTPs (10mM), 1.0μl 
random hexamers, 0.4μl RNase inhibitor, 1.25 MultiScribe reverse transcriptase, 7μl RNA, 
and nuclease free water [the amount of RNA used gave a final amount of 1μg, nuclease-free 
water was added to bring the combined RNA/water volume to 7μl]). One cycle was used 
(25˚C for 10 minutes, 37˚C for 60 minutes, and 95˚C for 5 minutes). All reagents were 
supplied by Applied Biosystems (Warrington, UK). 
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3 RESULTS 
3.1 Digestion of the PCS2+ vector 
 
Probes were required for the PAPSS2a and PAPSS2b genes in order to carry out in situ 
hybridisations. The genes of interest needed to be ligated into the vector PCS2+ to form a 
construct. The EcoR1 site was selected as the point of ligation. 
 
The successful digestion of the vector by EcoR1 allows for the gene of interest to be ligated 
into it. The PCS2+ cloning vector was digested using EcoR1 as described in section 3.6. The 
product was then run on a gel to confirm that the digestion had been successful (figure 2). 
 
Figure 2 Digestion of PCS2+ vector 
The image of the 0.8% gel confirms that the PCS2+ vector was successfully digested. An 
undigested control was also used. The digest is shown in the first lane, and the undigested 
control is shown in the second lane. As can be seen the control has a size of around 600bp 
and the digest has a size between 4000bp and 6000bp 
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3.2 PCR of PAPSS2b 
 
PCR was carried out using self-designed primers shown in 3.7. The PCR was performed in 
order to obtain gene products to be ligated into the PCS2+ vector so that they could be used for 
the in situ hybridisation experiments. We aimed to produce gene products of three different 
sizes for both PAPSS2a and PAPSS2b. The first was a full length mRNA including the UTR, 
the second was only the coding section of the gene, and the third was a short segment from 
the 3’ end of the gene (short). 
 
PCR was performed using both fusion and blue methods (3.7). The temperatures used 
included 41˚C, 50˚C, 52˚C, 54˚C, 55˚C, 60˚C, 63˚C, and, 65˚C. The templates used were 
either 2 and 3 day embryo cDNA, PAPSS2b mRNA which I had produced as outlined in 3.7 
or adult zebrafish ovary cDNA. The volume of MgCl2 was also varied with 2μl, 4μl, and 6μl 
used. The elongation times were also varied between 30 seconds and 1.5minutes. Different 
primers for PAPSS2b were also used. 
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Figure 3  PAPSS2b mRNA. 
The image shows the 0.8% gel image of the bands which had been produced by the PCR while 
using fusion mix, with a temperature of 55˚C and using 2/3 day cDNA. The primers which 
were used were for PAPPS2a; full length mRNA, coding region, and short, and PAPSS2b; 
mRNA, cDNA, and short. The band showing that PAPSS2b mRNA has successfully been 
amplified can clearly be seen. The PAPSS2b mRNA band is located at 2695bp in size. 
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Figure 4 PAPSS2b and short  
The image shows the 0.8% gel image of the PCR reactions which had been produced by the 
PCR while using fusion mix, with a temperature of 60˚C and using 2/3 day cDNA. The 
primers which were used were for PAPPS2a; mRNA, cDNA and short, and PAPSS2b; mRNA, 
cDNA, and short. The band showing that PAPSS2b short has successfully been amplified can 
clearly be seen in the fifth row from the hyperladder 1. The PAPSS2b short band is located 
around 918bp in size. 
 
 
Figure 5 PAPSS2b short 
The image shows the 0.8% gel image of the PCR reactions which had been produced by the 
PCR while using fusion mix, with a temperature of 41˚C and using the mRNA that I had 
produced as the template. The primers which were used were for PAPSS2b; cDNA, and short. 
The bands showing that PAPSS2b short has successfully been amplified can clearly be seen in 
the second, third, forth and fifth lanes from the hyperladder 1. The PAPSS2b short band is 
918bp in size. 
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I was able to successfully produce a cDNA band representing the full length mRNA and the 
shortened version of the mRNA for the PAPSS2b gene using differing conditions for the 
PCR. The samples which had been run on the gel containing the mRNA could then be excised 
from the gel and purified. These mRNA samples were then ligated into the PCS2+ vector. 
3.3 Colony PCR 
 
Following the ligation of the vector and the PCR amplified insert the resulting vector was 
transformed into E.Coli, and then plated on agar plates. From here 25 colonies were selected 
for colony PCR. Following this the PCR was run on 8% gel and four colonies were selected 
which were identical to the positive control. A negative control of water was also used. 
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Figure 6 PAPSS2b mRNA insert. 
The image shows the 8% gel print out of the solutions which had been produced by the colony 
PCR for the transformations which included the PAPSS2b mRNA insert. The third, fifth, sixth 
and nineteenth colony was selected. 
 
Figure 4 shows which of the colonies contained the vector. The four which were selected 
were chosen due to firstly containing the insert and secondly because they most closely 
resembled the positive control. 
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Plasmid DNA was extracted by mini-prep as described in section 3.4 and the presence of the 
insert was confirmed by restriction digest with EcoR1 as described in section 3.6. 
 
Figure 7 Mini-prep 
The image shows the 0.8% gel image of the PCR reaction which had been produced by the 
mini-prep. These are the mini-preps of the colonies selected from figure 4. As can been seen 
three of the colonies still contain the insert. 
 
As can be seen the insert is still present within three of the colonies and these can be used for 
further experiments. The sample was then excised from the gel, purified, and then sent for 
sequencing to confirm that the sequence is correct. The following primers were used for the 
sequencing: 
PAPSS2b fwd 431 aagtgtttgtaaatgctc 
PAPSS2b fwd 882 tgttccaattgtgcttc 
PAPSS2b fwd 1425 catcgtggccattttc 
PAPSS2b fwd 1692 cgacaaggaaagacatg 
PAPSS2b rev 198 gactagatattcttccag 
PAPSS2b rev 647 ggtacaatatcctgttc 
PAPSS2b rev 1095 cagccaatccccac 
PAPSS2b rev 1490 cgacaatgccattgtac 
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This allowed for a comparison between the genomic sequence and the cloned sequence which 
had been produced to confirm that the sequence was correct. Sequencing analysis confirmed 
that the insert was correct and could therefore be used successfully in future work. 
3.4 In situ hybridisation 
 
Embryos were selected and fixed at day 1, day 2, and day 3 following fertilisation. In situ 
hybridisation was then carried out on these embryos and images obtained. Sense and anti-
sense probes which had previously been produced for PAPSS2b mRNA and PAPSS2b short 
transcript were used to identify the location of the PAPSS2b gene within the zebrafish at these 
time points. The sense probes provided a control, whereas the anti-sense probes allowed for 
the location of the PAPSS2b gene expression at the given time points to be revealed. This also 
allowed for confirmation that the PAPSS2b was being expressed within the zebrafish at these 
developmental stages. 
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Figure 8 In situ day 1 PAPSS2b mRNA probe 
The images show the distribution of the PAPSS2b gene within the zebrafish 24 hours post-
fertilisation with the use of the PAPSS2b mRNA probe. The blue colour indicates the staining 
with the anti-sense probe. At this time there is staining of the brain, immature eye, and somite. 
 
 
 
 
 
 
 
 
Figure 9 In situ day 1 PAPSS2b short probe. 
The images show the distribution of the PAPSS2b gene within the zebrafish 24 hours post-
fertilisation with the use of the PAPSS2b short probe. The blue colour indicates the staining 
with the anti-sense probe. At this time there is staining of the brain, immature eye, and somite. 
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Figure 10 In situ day 2 PAPSS2b short probe 
The images show the distribution of the PAPSS2b gene within the zebrafish 48 hours post-
fertilisation with the use of the PAPSS2b short probe. The blue colour indicates the staining 
with the anti-sense probe. At this time there is staining of the brain, mid-brain/hind-brain 
boundary, eye, hatching gland, and somite. 
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Figure 11 In situ day 2 PAPSS2b mRNA probe 
The images show the distribution of the PAPSS2b gene within the zebrafish 48 hours post-
fertilisation with the use of the PAPSS2b mRNA probe. The blue colour indicates the staining 
with the anti-sense probe. At this time there is staining of the brain, mid-brain/hind-brain 
boundary, eye, hatching gland, and somite. 
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Figure 12 In situ day 3 PAPSS2b short probe 
The images show the distribution of the PAPSS2b gene within the zebrafish 72 hours post-
fertilisation with the use of the PAPSS2b short probe. The blue colour indicates the staining 
with the anti-sense probe. At this time there is staining of the brain, eye, and fin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 In situ day 3 PAPSS2b mRNA probe 
The images show the distribution of the PAPSS2b gene within the zebrafish 72 hours post-
fertilisation with the use of the PAPSS2b mRNA probe. The blue colour indicates the staining 
with the anti-sense probe. At this time there is staining of the brain, and eye. 
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The in situ hybridisation confirmed the presence of the PAPSS2b gene to be present within 
the zebrafish during days 1, 2, and 3. Both short and mRNA probes were used in order to see 
if it was possible to get more specific staining with different length probes. At day 1 the 
PAPSS2b gene is present in the brain, the immature eye, and the somite as shown in figures 8 
and 9. Figure 8 shows PAPSS2b presence confirmed by use of the mRNA probe and figure 9 
shows PAPSS2b presence confirmed by the short probe. At day 2 the PAPSS2b gene is 
present in the brain, mid-brain/hind-brain boundary, the eye, the hatching gland, and the 
somite as shown in figures 10 and 11. Figure 10 shows PAPSS2b presence confirmed by use 
of the short probe and figure 11 shows PAPSS2b presence confirmed by the mRNA probe. At 
day 3 the PAPSS2b gene is present in the brain, the eye, the fin as shown in figure 12 using 
the short probe. Also at day 3 the PAPSS2b gene is shown to be present in the brain and the 
eye as shown in figure 13 
3.5 Morpholino knock-down of PAPSS2b using splice site and translational 
blocking morpholinos 
 
The morpholino knock-down of the PAPSS2b gene was performed using splice site and 
translational blocking morpholinos to see if the knock-down resulted in a phenotypic change 
in the developing embryo. The splice site morpholino was positioned across an intron exon 
boundary and resulted in exon skipping leading to a functional mutation. The translational 
blocking morpholino was positioned over the ATG start site and resulted in a decrease in gene 
product being produced. 
 
In Situ hybridisation was also carried out on the embryos injected with the morpholios at days 
1, 2, and 3, using both the mRNA probe and the short probe. The staining from the in situs 
produced from the morpholinos was the same as was seen for the control embryos at the 
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respective time points (data not shown).  The embryos were injected with morpholinos at 
differing concentrations in order to see the effect of a morpholio knock down of the PAPSS2b 
gene within the developing zebrafish. Both splice acceptor and translational blocking targeted 
morpholinos were used at four differing concentrations (10μM, 30μM, 100μM, and 300μM) 
in order to find the optimum concentration. The changes in the patterns of development were 
compared to embryos which had been injected with a scramble morpholino at the 
corresponding concentration which acted as the control. The embryos were imaged at day 3, 
and day 4 as these showed developmental changes in the zebrafish. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 Scramble morpholino and PAPSS2b splice morpholino (300μM) day 3 
The images show the scramble morpholino (A, C) and the PAPSS2b splice morpholino (B, D) 
phenotypes at day 3 following injection. In B the PAPSS2b splice morpholino appears to have 
a squashed head in camparison to A and also the eye appears closer to the top of the head. 
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Figure 155 Scramble morpholino and PAPSS2b translational blocking morpholino (300μM) 
day 3 
The images show the scramble morpholino (A, C) and the PAPSS2b translation blocking 
morpholino (B, D) phenotypes at day 3 following injection. In B the PAPSS2b translational 
blocking morpholino appears to have a squashed head in camparison to A and also the eye 
appears closer to the top of the head. 
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Figure 166 Scramble morpholino and PAPSS2b splice morpholino (300μM) day 4 
The images show the scramble morpholino (A, C) and the PAPSS2b splice morpholino (B, D) 
phenotypes at day 4 following injection. The head of the splice morpholino (B) appears to be 
smaller than that of the control scramble morpholino, A. 
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Figure 1717 Scramble morpholino and PAPSS2b translational blocking morpholino (300μM) 
day 4 
The images show the scramble morpholino (A, C) and the PAPSS2b translational blocking 
morpholino (B, D) phenotypes at day 4 following injection. The translational blocking 
morpholino, B appears to have a smaller and more compact head than the control, scramble 
morpholino, B. 
 
 
When the translational blocking morpholino (figure 15 and 17) and the scramble morpholino 
(figure 14 and 16) were used for PAPSS2b there was a change in phenotype when a 
concentration of 300μM was used at days 3 and 4. The morpholino heads appear smaller and 
also more compacted. The eyes are also closer to the top of the head at day 3. There were a 
total of 52 embryos injected with the 300μM scramble morpholino which were analysed and 
at days 3 and 4, of these two showed the smaller head phenotype. There were a total of 54 
embryos injected with the 300μM translational blocking morpholino of which 32 showed the 
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smaller head phenotype at day 3, and 37 showed the phenotype at day 4. There were a total of 
51 embryos injected with the 300μM splice site morpholino of which 25 showed the smaller 
head phenotype at day 3, and 29 showed the phenotype at day 4. 
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4 DISCUSSION 
 
4.1 In Situ hybridisation of day 1, 2, and 3 zebrafish embryos using PAPSS2b 
probes 
 
Day 1, 2, and 3 zebrafish embryos were successfully stained using both full length mRNA 
PAPSS2b probes and also short length PAPSS2b probes, which had previously been produced 
(3.7). This allowed for both confirmation of the presence of PAPSS2b at these developmental 
stages and also for the localisation of PAPSS2b to be established within the developing 
zebrafish embryo. 
The in situ hybridisations were carried out at days 1, 2 and 3 post-fertilisation. Two separate 
probes were used, a probe for full-length mRNA and a short probe for PAPSS2b which had 
been cloned into the PCS2+ vector. Both sense and anti-sense probes were used for each of the 
constructs, for each the staining was stopped at differing time points in order to observe the 
full staining profile. Also once there was staining observed with the sense probe all of the 
staining samples were stopped as this is an indication that non-specific staining was starting to 
take place. The in situ hybridisations revealed at what point during development the PAPSS2b 
gene is expressed and its localisation. 
 
At day 1 staining was localised to the muscle, the eye and the somite of which muscle is the 
major derivative. At day 2 the staining was primarily located within the brain, the mid-
brain/hind brain barrier, the eye and the hatching gland. On day 3 the staining was seen within 
the brain, the eye, the fin and the blood vessels. Also the eye showed layering in its staining. 
On day three effective and accurate staining was harder due to the later stage embryos being 
harder to permiablise. This may lead to areas which have PAPSS2b expression not being 
stained and therefore overlooked. Ideally the in situs would have been repeated three times in 
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order to draw accurate comprehensive conclusions, although due to time restrictions this was 
not possible. The location of the staining is different to where the expression of PAPSS2b has 
been found in previous studies. Previous studies have shown it to be expressed in liver, 
cartilage and adrenal glands[8] which is not where it was found in these in situs. Also animal 
studies have indicated that PAPSS2 is the more abundant isoenzyme in developing tissues 
that have a high sulphonation requirement, such as cartilage. The difference could be due to a 
species difference or due to the staining of these areas being hard to distinguish. Therefore 
future work could involve using staining markers for the liver and interrenal organ in order for 
a more precise location of the staining to be found. 
4.2 Morpholino knock-down of PAPSS2b using translational blocking and splice 
site morpholinos 
 
The morpholinos used were a translational blocking morpholino, a splice morpholino and a 
scramble morpholino which acted as the control. The morpholinos were injected at four 
concentrations (10μM, 30μM, 100μM, and 300μM) for the PAPSS2b gene. The morpholinos 
at 10μM and 30μM did not give a successful knock-down of the PAPSS2b gene. This could 
be due to several factors, firstly it could be due to an injection error where the morpholino 
solution was not injected into the correct place. Alternatively the morpholino concentrations 
used may not have been high enough to lead to a successful knock-down of the gene as the 
gene may have been produced in too high a quantity for the morpholino to be able to decrease 
the overall product enough. When the higher concentrations were used (100μM, and 300μM) 
there was successful knock-down of the PAPSS2b gene by both the splice morpholino and the 
translational blocking morpholino, however the knock-down was only slight for 100μM and 
there was considerable knock-down for 300μM. The development of the treated embryos was 
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observed throughout the following four days following injection and images were taken at 
days 3 and 4 to document the appearance.  
 
There was no clear change in the phenotype of the morpholino treated embryos with respect 
to the scramble morpholino treated control embryos at 10μM, 30μM and 100μM 
concentrations. When 300μM concentration was used there was a noticeable change in the 
phenotype although subtle (figures 14, 15, 16, and 17) for PAPSS2b knock-down. This was 
that the heads of the embryos injected with the translational blocking morpholino and the 
splice morpholino were smaller and more compact that those injected with the scramble 
morpholino control. Also at day three the eyes appeared closer to the top of the head when 
compared to the control. The number of morpholino injected embryos exhibiting this 
phenotype was quantified and shown to be substantial. Due to the size of the head being 
smaller in the PAPSS2b knock-down embryos this could be a result of a defect in the cartilage 
development within this area as it has already been shown that cartilage development is 
affected by a PAPSS2b gene mutation in a previous study[2]. This fits in well with previous 
studies in mice which have shown that when there are defects in the PAPSS2 gene there are 
consequential bone defects. 
 
This project has started to look into the functions of the PAPSS isoforms in zebrafish, 
however since these are pilot studies further studies will be required to confirm the exact 
nature of their role. 
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4.3 Future work 
 
Future work to continue this project could include a double knock-down of the morpholino 
where both PAPSS2a and PAPSS2b are both knocked-down within the same embryo. This is 
due to the hypothesis that PAPSS2a could be compensating for the knock-down of PAPSS2b 
and that PAPSS2b could be compensating for the knock-down of PAPSS2a. So by knocking 
down both of the genes simultaneously it would eliminate this possible compensation. Also 
due to the phenotype change seen with the morpholino knock-down at 300μm being slight it 
could be that the phenotype is subtle and this could be investigated further. For example with 
bone, liver, or interrenal staining. Also latter stages of development could be investigated in 
order to see if there is more effect of a gene knock-down latter in development. 
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